Research Papers:

DDEFL1 correlated with Rho GTPases activity in breast cancer

Xiaoyun Mao, Chuifeng Fan, Xinmiao Yu, Bo Chen and Feng Jin _

PDF  |  HTML  |  How to cite

Oncotarget. 2017; 8:112487-112497. https://doi.org/10.18632/oncotarget.22095

Metrics: PDF 1147 views  |   HTML 2194 views  |   ?  


Xiaoyun Mao1, Chuifeng Fan2, Xinmiao Yu1, Bo Chen1 and Feng Jin1

1Department of Breast Surgery, First Affiliated Hospital of China Medical University, Shenyang, Liaoning 110001, China

2Department of Pathology, First Affiliated Hospital and College of Basic Medical Sciences of China Medical University, Shenyang, Liaoning 110001, China

Correspondence to:

Feng Jin, email: [email protected], [email protected]

Keywords: DDEFL1, Rho GTPases, breast cancer

Received: August 14, 2017     Accepted: September 22, 2017     Published: October 26, 2017


DDEFL1 is related to maintaining a limiting amount of ARF6 in GTP-loaded form by accelerating its GTP hydrolysis activity, which has been implicated in hepatocellular cancer pathogenesis and lung cancer development. We investigated DDEFL1 expression in breast cancer and paired normal breast tissues by immunohistochemistry and found that DDEFL1 expression was significantly associated with tumor size, lymph node metastasis, high content of elastosis and TNM stage but not with menopausal status or age. We detected the mRNA and protein expression of DDEFL1 in breast cancer cell lines by Western blotting and quantitative real-time PCR (qRT-PCR). DDEFL1 was obvious in MDA-MB-435s and MDA-MB-231 but very weak in ZR-75-1. Further experiments were conducted to evaluate the effect of DDEFL1 small interfering RNA (siRNA) transfection on the biological behavior of MDA-MB-231. After transfection, the effects of DDEFL1 inhibition on expression of mRNA and protein were also analyzed by Western blotting and qRT-PCR. Increased apoptosis and invasive ability, decreased cellular proliferation was found in MDA-MB-231 with successful DDEFL1 siRNA transient transfection (p < 0.05). Western blotting and qRT-PCR results showed that the DDEFL1 inhibition up-regulated Caspase-3, Apaf-1, cytochrome c, and Bax expression and down-regulated Bcl-2 expression. The DDEFL1 inhibition also down-regulated the mRNA and protein expression of Rho, CDC42 and Rac1. Our study provided a functional linkage through DDEFL1 with breast cancer biological behaviours by Rho GTPases. Possible implication of our main finding for the DDEFL1 role in breast cancer and the downstream signaling pathways for the treatment of breast cancer.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 22095